Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CpG DNA refers to regions of DNA where a cytosine nucleotide is followed by a guanine nucleotide. These sites are crucial for epigenetic regulation, with methylation leading to gene silencing and unmethylation enabling transcription. Unmethylated CpG motifs also act as pathogen-associated molecular patterns (PAMPs), activating the innate immune system. Synthetic CpG oligodeoxynucleotides (CpG ODNs) are used as immunostimulatory agents and vaccine adjuvants.
CpG ODNs activate innate immune cells (macrophages, dendritic cells, NK cells, B cells) through pattern recognition receptors. Methylation status of CpG dinucleotides influences gene expression by affecting chromatin accessibility and transcription factor binding.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytosine-phosphate-Guanine DNA (CpG DNA).